GLIOSTRY (GLIOBLASTOMA REGISTRY) OF THE AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY): FINAL ANALYSIS OF FACTORS INFLUENCING SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING THE NITROSOUREA FOTEMUSTINE AT FIRST PROGRESSION FOLLOWING CHEMORADIATION.

被引：0
|
作者：
Ruda, R. [1 ,2 ]
Lombardi, G. [3 ]
Scoccianti, S. [4 ]
Pasqualetti, F. [5 ]
Silvani, A. [6 ]
Pace, A. [7 ]
Arcicasa, M. [8 ]
Salvati, M. [9 ]
Caroli, M. [10 ]
Soffietti, R. [1 ,2 ]
机构：
[1] Univ Turin, Dept Neurooncol, Turin, Italy
[2] City Hlth & Sci Hosp, Turin, Italy
[3] Ist Oncol Veneto, Padua, Italy
[4] Univ Florence, Dept Radiotherapy, Florence, Italy
[5] Univ Pisa, Pisa, Italy
[6] Neurol Besta Inst, Milan, Italy
[7] IFO Roma, Rome, Italy
[8] CRO, Aviano, Italy
[9] Univ Roma La Sapienza, Rome, Italy
[10] Univ Milan, Milan, Italy
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P08.33
引用
收藏
页码：48 / 48
页数：1
相关论文
共 18 条
  • [1] GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology): Analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first relapse following Stupp regimen.
    Ruda, Roberta
    Lombardi, Giuseppe
    Scoccianti, Silvia
    Fabrini, Maria Grazia
    Santoni, Matteo
    Pace, Andrea
    Silvani, Antonio
    Marinelli, Alfredo
    Lolli, Ivan
    Balducci, Mario
    Arcicasa, Mauro
    Salvati, Maurizio
    Sponghini, Andrea
    Vallarelli, Simona
    Caroli, Manuela
    Imbesi, Francesca
    Bilancia, Domenico
    Faedi, Marina
    Cascinu, Stefano
    Soffietti, Riccardo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Predictors of survival in glioblastoma patients treated with fotemustine at first relapse after Stupp regimen: Analysis of GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)
    Lombardi, G.
    Scoccianti, S.
    Fabrini, M. G.
    Santoni, M.
    Villani, V.
    Silvani, A.
    Marinelli, A.
    Lolli, I.
    Balducci, M.
    Arcicasa, M.
    Salvati, M.
    Sponghini, A.
    Vallarelli, S.
    Caroli, M.
    Imbesi, F.
    Bilancia, D.
    Faedi, M.
    Zagonel, V.
    Soffietti, R.
    Ruda, R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S584 - S584
  • [3] Prognostic factors in glioblastoma patients treated with the nitrosourea fotemustine at first relapse after the Stupp regimen: results from the GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)
    Santoni, M.
    Lombardi, G.
    Scoccianti, S.
    Fabrini, M. G.
    Silvani, A.
    Villani, V.
    Marinelli, A.
    Lolli, I.
    Balducci, M.
    Arcicasa, M.
    Salvati, M.
    Sponghini, A. P.
    Vallarelli, S.
    Caroli, M.
    Imbesi, F.
    Bilancia, D.
    Faedi, M.
    Cascinu, S.
    Soffietti, R.
    Ruda, R.
    ANNALS OF ONCOLOGY, 2015, 26 : 133 - 133
  • [4] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
    Riccardo Soffietti
    Elisa Trevisan
    Luca Bertero
    Paola Cassoni
    Isabella Morra
    Maria Grazia Fabrini
    Francesco Pasqualetti
    Ivan Lolli
    Anna Castiglione
    Giovannino Ciccone
    Roberta Rudà
    Journal of Neuro-Oncology, 2014, 116 : 533 - 541
  • [5] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
    Soffietti, Riccardo
    Trevisan, Elisa
    Bertero, Luca
    Cassoni, Paola
    Morra, Isabella
    Fabrini, Maria Grazia
    Pasqualetti, Francesco
    Lolli, Ivan
    Castiglione, Anna
    Ciccone, Giovannino
    Ruda, Roberta
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (03) : 533 - 541
  • [6] Bevacizumab and Fotemustine for Recurrent Glioblastoma - Final Results of a Multicenter Phase II Study of AINO (Italian Association of Neuro-Oncology)
    Trevisan, E.
    Ruda, R.
    Bertero, L.
    Bosa, C.
    Ciccone, G.
    Morra, I.
    Fabrini, M. G.
    Lolli, I.
    Soffietti, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S576 - S576
  • [7] PHASE II TRIAL OF BEVACIZUMAB WITH FOTEMUSTINE IN RECURRENT GLIOBLASTOMA: FINAL RESULTS OF A MULTICENTER STUDY OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
    Soffietti, Riccardo
    Trevisan, Elisa
    Ruda, Roberta
    Bertero, Luca
    Bosa, Chiara
    Fabrini, Maria Grazia
    Lolli, Ivan
    NEURO-ONCOLOGY, 2011, 13 : 56 - 57
  • [8] Phase II trial of bevacizumab with fotemustine in recurrent glioblastoma: Final results of a multicenter study of AINO (Italian Association of Neuro-oncology).
    Soffietti, R.
    Trevisan, E.
    Ruda, R.
    Bertero, L.
    Bosa, C.
    Fabrini, M. G.
    Lolli, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Clinical and molecular predictors of survival in elderly glioblastoma patients treated with radiotherapy and concomitant temozolomide: a multicenter study of aino (Italian Association of Neuro-Oncology)
    Lombardi, G.
    Pace, A.
    Pasqualetti, F.
    Rizzato, S.
    Faedi, M.
    Anghileri, E.
    Nicolotto, E.
    Bazzoli, E.
    Bellu, L.
    Villani, V.
    Fabi, A.
    Ferrazza, P.
    Gurrieri, L.
    Dall'Agata, M.
    Eoli, M.
    Della Puppa, A.
    Pambuku, A.
    Berti, F.
    Ruda, R.
    Zagonel, V.
    ANNALS OF ONCOLOGY, 2015, 26 : 136 - 136
  • [10] Temozolomide (TMZ) and radiation therapy (RT) combination in elderly patients with glioblastoma: A multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
    Lombardi, Giuseppe
    Pace, Andrea
    Pasqualetti, Francesco
    Rizzato, Simona
    Faedi, Marina
    Anghileri, Elena
    Nicolotto, Elisa
    Bazzoli, Elena
    Bellu, Luisa
    Villani, Veronica
    Fabi, Alessandra
    Ferrazza, Patrizia
    Gurrieri, Lorena
    Dall'Agata, Monia
    Eoli, Marica
    Della Puppa, Alessandro
    Pambuku, Ardi
    D'Avella, Domenico
    Ruda, Roberta
    Zagonel, Vittorina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12